TAF9 Antikörper (N-Term)
Kurzübersicht für TAF9 Antikörper (N-Term) (ABIN927497)
Target
Alle TAF9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Rind (Kuh), Hund, Kaninchen, Huhn, Frosch
-
Aufreinigung
- Purified
-
Immunogen
- TAF9 antibody was raised in rabbit using the N terminal of TAF9 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.125 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
TAF9 Blocking Peptide, (ABIN938788), is also available for use as a blocking control in assays to test for specificity of this TAF9 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))
-
Andere Bezeichnung
- TAF9
-
Hintergrund
- Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. Synonyms: Polyclonal TAF9 antibody, Anti-TAF9 antibody, TAF9 RNA polymerase II, TATA box binding protein, TBP-associated factor, 32kDa antibody.
-
Pathways
- Negative Regulation of intrinsic apoptotic Signaling
Target
-